Mount Sinai Researchers Make Immunotherapy Work for Treatment-Resistant Lymphoma
August 02, 2019
August 02, 2019
NEW YORK, Aug. 2 -- The Mount Sinai Health System issued the following news release
* * *
- Transplanting T-Cells Boosts Efficacy of Immunotherapies in Several Cancers
* * *
Mount Sinai researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin's lymphomas for the first time by combining them with stem cell transplantation, an approach that also dramatically increased the success of the drugs in melanoma . . .
* * *
- Transplanting T-Cells Boosts Efficacy of Immunotherapies in Several Cancers
* * *
Mount Sinai researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin's lymphomas for the first time by combining them with stem cell transplantation, an approach that also dramatically increased the success of the drugs in melanoma . . .